Venture Capital
San Francisco, California, 94129
Logos Capital is a fundamental biotechnology-focused investment partnership that combines scientific and financial expertise with in-house clinical trial analytics to identify transformative therapies in healthcare. Based in San Francisco, Logos combines expertise across medical, scientific, and statistical disciplines to expand the depth of diligence in identifying compelling investment themes and opportunities. Success in drug development is contingent on more than just scientific research. Our process focuses on event tracking, clinical trial underwriting, risk management, and a culture rooted in technical diligence and continuous improvement. We seek to holistically assess an asset from its preclinical data through commercialization potential to determine intrinsic value.
101224sbs
